Chime Biologics is a leading CDMO that enables its partners’ success in biologics. By leveraging our innovative R&D and manufacturing capabilities, we empower the entire biologics processes – from cell line development to commercial manufacturing – enabling customers to deliver affordable and accessible biologics that benefit patients worldwide.
With over 400 skilled employees, Chime Biologics leverages its comprehensive capabilities and internationally-recognized expertise to provide one-stop integrated solutions to worldwide customers. Relying on cell line development and advanced technology development from its Chime Biologics Innovation Center in Shanghai and proven success in IND-enabling through NDA/BLA filing at its Wuhan campus, Chime Biologics is providing highquality pre-clinical, clinical and commercial manufacturing solutions.
Chime Biologics success is driven by reliable, compliant, flexible and fast-paced services from its innovative talent and operational excellence. We share a common goal to make cutting-edge biologics affordable and accessible to all patients globally, fulfilling its commitment to human health.
We offer flexible biomanufacturing solutions at diverse scales, our World’s first KuBio facility is featured with various bioreactor sizes ranging from 50L, 200L, 500L to 2000L. The production capacity can be rapidly adjusted according to the customization requirement, catering to your need for projects at different development stages. The facility is designed to meet the requirements of NMPA, EMA, US FDA and PIC/S GMP standard. Our state-of-the-art filling facility provides fully automated final drug product formulation and aseptic processing to facilitate seamless path to clinic.
Corporate Highlights：
1) Provided clinical trial materials to more than 20 countries, including 1 commercial product
2) More than 50 2,000L GMP batches produced successfully, mainly for Phase Ⅱ/Ⅲ trials
and commercial manufacturing
3) cGMP compliant with ICH, FDA, EMA, and NMPA standards
4) Obtained commercial manufacturing license from NMPA
5) Senior management team with average 30 years of in-depth international biotech industry experience
With over 400 skilled employees, Chime Biologics leverages its comprehensive capabilities and internationally-recognized expertise to provide one-stop integrated solutions to worldwide customers. Relying on cell line development and advanced technology development from its Chime Biologics Innovation Center in Shanghai and proven success in IND-enabling through NDA/BLA filing at its Wuhan campus, Chime Biologics is providing highquality pre-clinical, clinical and commercial manufacturing solutions.
Chime Biologics success is driven by reliable, compliant, flexible and fast-paced services from its innovative talent and operational excellence. We share a common goal to make cutting-edge biologics affordable and accessible to all patients globally, fulfilling its commitment to human health.
We offer flexible biomanufacturing solutions at diverse scales, our World’s first KuBio facility is featured with various bioreactor sizes ranging from 50L, 200L, 500L to 2000L. The production capacity can be rapidly adjusted according to the customization requirement, catering to your need for projects at different development stages. The facility is designed to meet the requirements of NMPA, EMA, US FDA and PIC/S GMP standard. Our state-of-the-art filling facility provides fully automated final drug product formulation and aseptic processing to facilitate seamless path to clinic.
Corporate Highlights：
1) Provided clinical trial materials to more than 20 countries, including 1 commercial product
2) More than 50 2,000L GMP batches produced successfully, mainly for Phase Ⅱ/Ⅲ trials
and commercial manufacturing
3) cGMP compliant with ICH, FDA, EMA, and NMPA standards
4) Obtained commercial manufacturing license from NMPA
5) Senior management team with average 30 years of in-depth international biotech industry experience
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
